insiderwall
Menu
SuperinvestorInsider
bioMérieux SA BIM

Super Investor & Insider

Nessuna transazione insider negli ultimi 6 mesi.

Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.

About

bioMérieux SA is a family-owned French company and a world leader in the field of in vitro diagnostics, founded in 1963 by the Mérieux family. It pioneers, develops, and produces high-quality diagnostic solutions to improve public health worldwide, with a core purpose of making the world a healthier place through innov…

SectorHealthcare
ExchangeXPAR
IndustryDiagnostics & Research
CountryFrance
Employees14,562
TickerBIM

Statistics

Market Cap$9.28B
Revenue (TTM)$4.07B
Net Income$396.9M
Net Margin9.8%
EPS—
P/E20.19
P/S1.95
P/B1.94
EV/EBITDA6.98
ROE9.5%
Dividend Yield5.76%
Price$78.66

Data: Twelve Data · Revenue = mcap / P/S

bioMérieux SA (BIM) — Azioni, fondamentali e superinvestor | InsiderWall